Vertex will pay millions to rival Editas Medicine and the Broad Institute so that it can sell its breakthrough gene editing treatment for sickle-cell disease.
Drug makers in Mass. and beyond are deploying gene editing, which snips sequences of patients’ DNA, to develop dozens of other treatments for cancers, heart disease, diabetes, and rare genetic disorders.
Vertex pays Editas $100M to use gene editing tech fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Gene-edited humans? First CRISPR-based gene therapy gets approved for clinical use in the U K – NaturalNews com naturalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naturalnews.com Daily Mail and Mail on Sunday newspapers.
The U.S. Food and Drug Administration has approved the marketing of two gene therapies for sickle cell disease, including the first treatment based on Crispr technology. These extremely costly.